Linking pages
- A new antiviral pill cuts COVID-19 hospitalization and death rates https://www.sciencenews.org/article/coronavirus-covid-antiviral-pill-merck-molnupiravir-hospitalization-death 460 comments
- Merck’s COVID-19 pill may soon be here. How well will it work? https://www.sciencenews.org/article/covid-pill-merck-molnupiravir-antiviral-fda 13 comments
- The arthritis drug tocilizumab doesn’t appear to help fight COVID-19 https://www.sciencenews.org/article/coronavirus-covid-19-arthritis-drug-tocilizumab-not-promising 10 comments
Linked pages
- Program Planner https://www.abstractsonline.com/pp8/#!/7891/presentation/35079 261 comments
- Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 | FDA https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 90 comments
- https://www.sciencedirect.com/science/article/pii/S0166354220302011 88 comments
- Merck Statement on Ivermectin use During the COVID-19 Pandemic - Merck.com https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/ 4 comments
- Antidepressant fluvoxamine could keep mild COVID-19 from worsening | Science News https://www.sciencenews.org/article/covid-19-coronavirus-antidepressant-fluvoxamine-treatment 4 comments
Related searches:
Search whole site: site:www.sciencenews.org
Search title: Why it’s still so hard to find treatments for early COVID-19
See how to search.